![Hugh Griffith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Griffith
Founder at
NUCANA PLC
Net worth: 327 600 $ as of 31/03/2024
Profile
Hugh Stephen Griffith was the founder of EdixoMed Ltd. (2011, Non-Executive Director), MedAnnex Ltd. (2009, Non-Executive Director), Thirty Holdings Ltd. (2018, Non-Executive Director), NuCana Plc (1997, Chief Executive Officer & Executive Director), and Alida Capital International Ltd. (2009, Chief Executive Officer & Director).
Former job at Ernco 200 LTD (2002, Executive Commercial Director), Abbott Laboratories (1995-2001, Manager-Business Development), Parke-Davis & Co. Ltd. (Principal), Warner Lambert (UK) Ltd. (1992-1995, Principal), and Bioenvision, Inc. (2002-2007, Chief Operating Officer).
Education at The University of Stirling (undergraduate) and Cardiff Business School (MBA).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUCANA PLC 3.96% | 18/03/2026 | 1,260,000 ( 3.96% ) | 327 600 $ | 31/03/2024 |
Hugh Griffith active positions
| Companies | Position | Start |
|---|---|---|
| NUCANA PLC | Founder | 28/01/1997 |
Former positions of Hugh Griffith
| Companies | Position | End |
|---|---|---|
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Founder | 01/01/2024 |
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Founder | 25/09/2023 |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Founder | 01/01/2023 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Chief Operating Officer | 01/12/2007 |
Ernco 200 LTD
 Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Corporate Officer/Principal | 01/09/2002 |
Training of Hugh Griffith
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Health Technology |
Warner Lambert (UK) Ltd.
 Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufacturer and wholesaler of pharmaceuticals and over the counter medicines | Health Technology |
The University of Stirling
 The University of Stirling Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Alida Capital International Ltd.
 Alida Capital International Ltd. Investment ManagersFinance Provides capital and practical assistance for emerging biopharmaceutical companies | Finance |
Cardiff Business School
 Cardiff Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Commercial Services |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Technology Services |
- Stock Market
- Insiders
- Hugh Griffith
